Sofinnova Venture Partners XI L.P. 13D and 13G filings for Rapport Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-14 3:59 pm Purchase | 2024-06-10 | 13D | Rapport Therapeutics, Inc. Common Stock RAPP | Sofinnova Venture Partners XI L.P. | 1,951,562 5.500% | 1,951,562 (New Position) | Filing |